Delivery Order SPE2DX22D0010-SPE2D825FHP12
- Not listed
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 20mg with a ceiling value of $2,386.80. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The contract involves no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $2,386.80 for Amphetamine Mix Tablets 20mg, with an ultimate completion date of August 18, 2025. This is a firm fixed price, non-set-aside contract awarded on August 15, 2025, with performance to take place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for Amphetamine Mix Tablets 5mg, with a ceiling value of $1,886.73 and a firm fixed price structure. The order is due for completion by August 4, 2025, and represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,267.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 5MG, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was issued to AmerisourceBergen's Corporate Office division, with performance taking place at the contractor's facility in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $2,791.98 to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 5mg on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This award represents a small-value transaction within...
- The Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $4,238.84 delivery order on July 28, 2025, for the supply of Amphetamine Mix Tablets 15mg. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action issued under AmerisourceBergen's larger...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,504.93 firm fixed-price delivery order contract is for the supply of 5mg amphetamine mix tablets, a pharmaceutical product. The contract has an ultimate completion date of June 25, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg tablets in quantities of 100 units, with a contract ceiling value of $3,857.54. This is a firm fixed-price delivery order with an ultimate completion date of September 10, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The work will be performed at the...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 units of 15 mg d-amphetamine tablets, with a contract value of $1,077.65. The award, issued on July 28, 2025, with an ultimate completion date of the same date, reflects a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for dextroamphetamine-amphetamine 20 mg tablets (100-count supply) valued at $3,150.09 under a firm fixed-price contract. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. The...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHP12Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Amphetamine Mix Tablets 20mg, with a ceiling value of $2,454.12 and an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract action under the company's broader relationship with the Defense Logistics Agency. This award falls under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products to support military healthcare programs globally. The company's federal contract portfolio demonstrates consistent capability in fulfilling diverse medical supply requirements, including controlled pharmaceuticals, specialty medications, and generic drugs across multiple therapeutic domains, serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 8/11/25 |